He aha ʻo Loncastuximab Tesirine: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

ʻO Loncastuximab tesirine he lāʻau lapaʻau maʻi maʻi i hoʻolālā ʻia e mālama i kekahi mau ʻano maʻi koko, ʻo ia hoʻi ka lymphoma cell B nui. Hana kēia lāʻau lapaʻau e like me ka missile alakaʻi, e hāʻawi ana i ka chemotherapy pololei i nā cell maʻi maʻi i ka wā e hoʻāʻo nei e mālama i nā ʻiʻo olakino. Hoʻokaʻawale ʻia ia no nā maʻi i hoʻi mai kā lākou maʻi maʻi a i ʻole ʻaʻole i pane i nā lāʻau lapaʻau ʻē aʻe, e hāʻawi ana i ka manaʻolana i ka wā i pau ai nā koho ʻē aʻe.

He aha ʻo Loncastuximab Tesirine?

ʻO Loncastuximab tesirine he antibody-drug conjugate, ʻo ia hoʻi, hoʻohui ia i kahi antibody i manaʻo ʻia me kahi lāʻau chemotherapy ikaika. E noʻonoʻo iā ia he ʻōnaehana hāʻawi akamai e ʻimi nei i nā cell maʻi maʻi a hāʻawi pololei i ka lāʻau lapaʻau iā lākou. Hoʻopili pono ka lāʻau lapaʻau i ka CD19, kahi protein i loaʻa ma ka ʻili o kekahi mau cell maʻi koko.

No kēia lāʻau lapaʻau i kahi papa hou o nā lāʻau lapaʻau maʻi maʻi e manaʻo nei e ʻoi aku ka pololei ma mua o ka chemotherapy kuʻuna. Ma kahi o ka hoʻopilikia ʻana i nā cell e mahele wikiwiki ana i kou kino, e kālele ana ia i kāna hoʻouka ʻana i nā cell maʻi maʻi e hōʻike ana i ka protein CD19. Hiki i kēia ala i manaʻo ʻia ke kōkua i ka hōʻemi ʻana i kekahi o nā hopena ʻaoʻao āu e ʻike ai me ka chemotherapy maʻamau.

Hāʻawi ʻia ka lāʻau lapaʻau intravenously, ʻo ia hoʻi, hāʻawi ʻia ma o ka vein i kou lima i loko o kahi manawa kikoʻī. E nānā pono kāu hui mālama ola iā ʻoe i ka wā a ma hope o kēlā me kēia infusion e hōʻoia e pane maikaʻi ana ʻoe i ka lāʻau lapaʻau.

No ke aha e hoʻohana ʻia ai ʻo Loncastuximab Tesirine?

Ua ʻae ʻia ʻo Loncastuximab tesirine e mālama i ka relapsed a i ʻole refractory large B-cell lymphoma. ʻO ia hoʻi, hoʻohana ʻia ia i ka wā i hoʻi mai ai kāu lymphoma ma hope o ka lāʻau lapaʻau mua a i ʻole ʻaʻole i pane pono i ʻelua mau lāʻau lapaʻau mua. E noʻonoʻo maʻamau kāu oncologist i kēia lāʻau lapaʻau i ka wā i kū ʻole ai nā lāʻau lapaʻau maʻamau.

ʻO ka lymphoma B-cell nui he ʻano o ka lymphoma non-Hodgkin e pili ana i kāu ʻōnaehana lymphatic, he ʻāpana o ka pūnaewele hakakā maʻi o kou kino. Ke wehewehe ʻia kēia maʻi maʻi ma ke ʻano he "relapsed," ʻo ia hoʻi ua hoʻi mai ia ma hope o kahi manawa o ka remission. ʻO "Refractory" ke ʻano ʻaʻole i pane maikaʻi ka maʻi maʻi i nā lāʻau lapaʻau mua a i ʻole i hoʻomau i ka ulu ʻana me ka ʻole o ka therapy.

Pono kāu kauka e hōʻoia i ka hōʻike ʻana o kāu mau sela maʻi maʻi i ka protein CD19 ma mua o ka ʻōlelo ʻana i kēia lāʻau lapaʻau. Hana ʻia kēia ma o ka hoʻāʻo ʻana i ka hale hana o kāu ʻiʻo maʻi maʻi. ʻAʻole kūpono nā lymphomas a pau no kēia lāʻau lapaʻau, ʻo ia ke kumu he mea nui ka hoʻāʻo kūpono ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau.

Pehea e hana ai ʻo Loncastuximab Tesirine?

Hana ʻo Loncastuximab tesirine ma ke ʻano he lāʻau lapaʻau maʻi maʻi ikaika a i manaʻo ʻia e hui pū ana i ka pololei me ka ikaika. Aia ka lāʻau lapaʻau i ʻelua ʻāpana nui: kahi antibody e hana ana e like me ka ʻōnaehana GPS e ʻimi i nā sela maʻi maʻi, a me kahi lāʻau chemotherapy ikaika e luku iā lākou ke hāʻawi ʻia. ʻO kēia ka mea e lilo ai i lāʻau lapaʻau ikaika i mālama ʻia no nā kūlana koʻikoʻi i ka wā i hana ʻole ai nā lāʻau lapaʻau ʻē aʻe.

Eia ke ʻano o ka hana ʻana o ke kaʻina hana i loko o kou kino. ʻO ka mea mua, ʻimi ka ʻāpana antibody a hoʻopaʻa i nā protein CD19 ma ka ʻili o kāu mau sela maʻi maʻi. Ke hoʻopili ʻia, komo ka lāʻau lapaʻau holoʻokoʻa i loko o ke keena maʻi maʻi. I loko o ke keena, hoʻokuʻu ʻia ka mea chemotherapy a hoʻomaka e luku i ka maʻi maʻi mai loko mai.

ʻO kēia ala i manaʻo ʻia, ʻo ia hoʻi, hiki i ka lāʻau lapaʻau ke hāʻawi i kahi mahele i manaʻo ʻia o ka chemotherapy pololei i nā sela maʻi maʻi me ka hōʻemi ʻana i ka ʻike ʻana i nā ʻiʻo olakino. Eia nō naʻe, no ka mea, he ikaika loa ka mea chemotherapy, hiki nō iā ʻoe ke ʻike i nā hopena ʻaoʻao no ka mea hiki ke hoʻopilikia ʻia kekahi mau sela olakino i ke kaʻina hana.

Pehea e lawe ai au iā Loncastuximab Tesirine?

Hāʻawi mau ʻia ʻo Loncastuximab tesirine ma ke ʻano he infusion intravenous ma kahi mālama olakino, ʻaʻole loa ma ke ʻano he pila āu e lawe ai ma ka home. E hāʻawi mālie kāu hui lapaʻau iā ia ma o ka vein i kou lima ma kahi o 30 mau minuke. Hele mai ka lāʻau lapaʻau i nā pōʻaiapuni, hāʻawi pinepine ʻia i kēlā me kēia ʻekolu pule, e ʻae ana i kou kino i ka manawa e ola ai ma waena o nā lāʻau lapaʻau.

Ma mua o kēlā me kēia infusion, e loaʻa paha iā ʻoe nā lāʻau lapaʻau mua e kōkua i ka pale ʻana i nā hopena maʻi a hoʻemi i ka pilikia o nā hopena ʻaoʻao. Hiki i kēia mau mea ke komo i nā antihistamines, steroids, a i ʻole nā mea hoʻemi wela. E nānā pono kāu hui mālama olakino i kāu mau hōʻailona ola i ka wā o ka infusion a no kekahi manawa ma hope e nānā i nā hopena koke.

ʻAʻole pono ʻoe e lawe i kēia lāʻau lapaʻau me ka meaʻai no ka mea ua hāʻawi ʻia intravenously. Eia naʻe, he mea nui e noho maikaʻi i ka wai i nā lā lapaʻau a e hahai i nā ʻōlelo kikoʻī a kāu hui mālama olakino e hāʻawi ai. Manaʻo kekahi poʻe maʻi he mea kōkua ke ʻai i ka meaʻai māmā ma mua o ka hele ʻana i ka lāʻau lapaʻau e kōkua i ka pale ʻana i ka nausea.

E hoʻolālā e hoʻolilo i kekahi mau hola ma ke kikowaena lapaʻau no kēlā me kēia kau. Aia kēia i ka manawa no nā lāʻau lapaʻau mua, ka infusion maoli, a me ka nānā ʻana ma hope o ka lāʻau lapaʻau. ʻO ka lawe ʻana i kahi puke, papa, a i ʻole ke loaʻa ʻana o kekahi e hele pū me ʻoe hiki ke kōkua i ka manawa e ʻoluʻolu ai.

Pehea ka lōʻihi e lawe ai au i ka Loncastuximab Tesirine?

ʻO ka lōʻihi o ka mālama ʻana i ka loncastuximab tesirine e pili ana i ka maikaʻi o ka pane ʻana o kāu maʻi maʻi a me ka pehea e ʻae ai kou kino i ka lāʻau lapaʻau. Loaʻa ka hapa nui o nā maʻi i ka lāʻau lapaʻau no kekahi mau pōʻaiapuni, me kēlā me kēia pōʻaiapuni i hoʻokaʻawale ʻia i ʻekolu pule. E loiloi mau kāu oncologist i kāu holomua ma o nā hoʻokolohua koko a me nā haʻawina kiʻi e hoʻoholo ai inā pono ʻoe e hoʻomau i ka lāʻau lapaʻau.

E hoʻomau ʻia ka mālama ʻana i ka wā e pane ana kāu maʻi ʻaʻai a ʻaʻole ʻoe e ʻike i nā hopena ʻaoʻao koʻikoʻi. Hiki i kekahi poʻe maʻi ke hoʻopau i kā lākou papa hana lapaʻau i hoʻolālā ʻia, a ʻo nā mea ʻē aʻe paha e pono e hooki koke inā paʻakikī loa nā hopena ʻaoʻao e mālama ai. E hana pū kāu hui mālama ola me ʻoe e ʻimi i ke kaulike kūpono ma waena o ka hakakā ʻana i kāu maʻi ʻaʻai a me ka mālama ʻana i kou maikaʻi o ke ola.

He mea nui nā manawa mālama maʻamau i ka wā o ka mālama ʻana. Hāʻawi kēia mau kipa i kāu kauka e nānā i ka maikaʻi o ka hana ʻana o ka lāʻau a hoʻoponopono i kāu hoʻolālā lapaʻau inā pono. E nānā nā hoʻokolohua koko i kāu helu ʻana i nā cell koko, ka hana ate, a me nā mea hōʻailona koʻikoʻi ʻē aʻe o ka pane ʻana o kou kino i ka mālama ʻana.

He aha nā hopena ʻaoʻao o Loncastuximab Tesirine?

Hiki i ka Loncastuximab tesirine ke hana i nā hopena ʻaoʻao, mai ka maʻalahi a i ke koʻikoʻi, i ka wā e pane ai kou kino i kēia lāʻau lapaʻau maʻi ʻaʻai ikaika. ʻO ka hoʻomaopopo ʻana i ka mea e manaʻo ai hiki ke kōkua iā ʻoe e hoʻomākaukau a ʻike i ka manawa e hoʻopili ai i kāu hui mālama ola. E hoʻomanaʻo ʻaʻole nā ​​mea a pau e ʻike i nā hopena ʻaoʻao a pau, a e hana pū kāu hui lapaʻau me ʻoe e mālama i nā mea e hiki mai ana.

ʻO nā hopena ʻaoʻao maʻamau āu e ʻike ai, ʻo ia ka luhi, ka nausea, a me nā helu cell koko haʻahaʻa. Loaʻa kēia mau hopena no ka mea e pili ana ka lāʻau lapaʻau i nā cell maʻi ʻaʻai a me kekahi mau cell olakino i kou kino. Nui ka poʻe maʻi e ʻike i kēia mau hōʻailona e mālama ʻia me ke kākoʻo kūpono a me nā lāʻau lapaʻau.

Eia nā hopena ʻaoʻao pinepine e hōʻike pinepine ai nā maʻi:

• Ka luhi a me ka nāwaliwali e mau ana ma waena o nā lāʻau lapaʻau
• Nausea a me ka luaʻi, ʻoi loa i nā lā mua ma hope o ka hoʻokomo ʻana
• Nā helu cell koko keʻokeʻo haʻahaʻa, e hoʻonui ana i ka pilikia o ka maʻi
• Nā helu platelet haʻahaʻa, e alakaʻi ana i ka ʻeha maʻalahi a i ʻole ke kahe ʻana
• Hoʻemi ʻia ka ʻai a me ka hiki ke lilo ke kaumaha
• ʻO ka ʻili ʻili a i ʻole ka ʻūlū ʻana ma nā wahi like ʻole
• Diarrhea a i ʻole nā ​​hoʻololi i nā hana ʻōpū
• ʻEha ʻiʻo a i ʻole nā ​​hui

Hiki ke mālama ʻia kēia mau hopena ʻaoʻao maʻamau me ka mālama kākoʻo a me nā lāʻau lapaʻau hiki i kāu hui mālama ola ke kuhikuhi.

Hiki i kekahi poʻe maʻi ke ʻike i nā hopena ʻaoʻao koʻikoʻi e koi ai i ka lāʻau lapaʻau koke. ʻO kēia mau pilikia kakaʻikahi akā koʻikoʻi e komo pū ana me nā maʻi koʻikoʻi ma muli o ka helu haʻahaʻa o nā keʻena koko keʻokeʻo, nā pilikia koko nui mai nā helu platelet haʻahaʻa, a i ʻole nā pilikia ate koʻikoʻi. Eia kekahi, hiki i kekahi poʻe maʻi ke hoʻomohala i kahi hopena ʻili koʻikoʻi i kapa ʻia ʻo Stevens-Johnson syndrome, e ʻike ʻia me ka ʻeha ʻeha o ka ʻili a me nā membrane mucous.

Eia nā hopena ʻaoʻao koʻikoʻi e koi ai i ka mālama olakino wikiwiki:

• Nā hōʻailona o ka maʻi koʻikoʻi e like me ke kuni, nā anu, a i ʻole ka ʻūlū mau
• Ke kahe koko ʻokoʻa a i ʻole ka ʻeha ʻaʻole e pau maʻalahi
• Nā hopena ʻili koʻikoʻi me ka ʻōpū a i ʻole ka ʻili ʻana
• Melemele o ka ʻili a i ʻole nā maka e hōʻike ana i nā pilikia ate
• ʻO ka luhi nui e keakea ana i nā hana o kēlā me kēia lā
• Paʻakikī ka hanu ʻana a i ʻole ka ʻeha o ka umauma
• ʻO ka nausea nui e pale ana iā ʻoe mai ka mālama ʻana i nā wai

E nānā pono kāu hui mālama ola iā ʻoe no kēia mau hopena a hāʻawi i ka lāʻau lapaʻau koke inā loaʻa. Mai kānalua e hoʻokaʻaʻike iā lākou inā ʻike ʻoe i nā hōʻailona e pili ana ma waena o nā manawa.

ʻO wai ka mea ʻaʻole pono e lawe iā Loncastuximab Tesirine?

ʻAʻole kūpono ʻo Loncastuximab tesirine no nā mea a pau, a e loiloi pono kāu oncologist inā ʻo ia ke koho kūpono no kāu kūlana kikoʻī. Hiki i kekahi mau maʻi olakino a i ʻole nā ​​kūlana ke hoʻolilo i kēia lāʻau lapaʻau i mea pilikia loa a i ʻole ka liʻiliʻi o ka hopena no kekahi poʻe maʻi. E nānā kāu hui lapaʻau i kāu mōʻaukala olakino piha ma mua o ka ʻōlelo ʻana i kēia lāʻau lapaʻau.

ʻAʻole paha he mau mea maikaʻi nā mea maʻi me ka maʻi ate koʻikoʻi no kēia lāʻau lapaʻau no ka mea hiki iā ia ke hoʻopilikia i ka hana ate. Pēlā nō, pono nā mea i loaʻa i nā maʻi koʻikoʻi, pono lākou e kali a hiki i ka wā e mālama ʻia ai ka maʻi ma mua o ka hoʻomaka ʻana i ka lāʻau. E noʻonoʻo nō kāu kauka i kou olakino holoʻokoʻa a me ka hiki ke ʻae i nā koi o ka lāʻau.

He mea nui ka hāpai ʻana a me ka hānai ʻana i ka waiū me kēia lāʻau lapaʻau. Hiki i ka Loncastuximab tesirine ke hōʻino i kahi pēpē e ulu ana, no laila pono nā wahine o ka makahiki hānau ke hoʻohana i ka contraception maikaʻi i ka wā o ka lāʻau a no kekahi mau mahina ma hope. Inā ʻoe e hānai ana i ka waiū, pono ʻoe e hooki ma mua o ka hoʻomaka ʻana i ka lāʻau.

Eia nā kūlana kikoʻī kahi i kūpono ʻole ai kēia lāʻau lapaʻau:

• Maʻi ate koʻikoʻi a i ʻole nā hoʻokolohua hana ate maʻamau ʻole
• Nā maʻi koʻikoʻi, ʻaʻole i mālama ʻia
• Hāpai a i ʻole nā hoʻolālā e hāpai
• Nā makuahine hānai waiū
• ʻO ka ʻōnaehana pale maʻi i hoʻopilikia nui ʻia mai nā kumu ʻē aʻe
• Nā lāʻau lapaʻau ola hou (pono e pale ʻia i ka wā o ka lāʻau)
• Nā pilikia puʻuwai koʻikoʻi e hoʻoweliweli ai i ka infusion

E kaupaona kāu oncologist i kēia mau mea i nā pōmaikaʻi e hiki mai ana o ka lāʻau e hana i ka ʻōlelo paipai maikaʻi loa no kou kūlana.

Inoa Brand Loncastuximab Tesirine

Ua kūʻai ʻia ʻo Loncastuximab tesirine ma lalo o ka inoa brand Zynlonta ma ʻAmelika Hui Pū ʻIa. ʻO kēia inoa brand ka mea āu e ʻike ai ma nā lepili lāʻau a me nā kūkākūkā me kāu hui mālama ola. Ua hoʻomohala ʻia ka lāʻau e ADC Therapeutics a ua loaʻa iā FDA ka ʻae no ka mālama ʻana i ka lymphoma cell B nui i hoʻihoʻi ʻia a i ʻole refractory.

I ka wā e kūkākūkā ana i kāu lapaʻau me nā hui ʻinikua a i ʻole nā hale kūʻai lāʻau lapaʻau, hiki ke hoʻohana ʻia ka inoa generic (loncastuximab tesirine) a me ka inoa brand (Zynlonta). E kōkua kāu hui mālama ola kino e hoʻopili me kāu ʻinikua e hōʻoia i ka uhi ʻana a e pane i nā nīnau e pili ana i ka loaʻa ʻana a i ʻole ke kumukūʻai o ka lāʻau.

Nā Koho ʻē aʻe no Loncastuximab Tesirine

Nui nā koho lapaʻau ʻē aʻe no ka lymphoma nui B-cell i hoʻi hou a i ʻole refractory, akā ʻo ke koho maikaʻi loa e hilinaʻi ana i kāu kūlana kikoʻī, nā lapaʻau ma mua, a me ke olakino holoʻokoʻa. E noʻonoʻo kāu oncologist i nā mea e like me nā ʻano o kāu maʻi kanesa, kāu pane ʻana i nā lāʻau lapaʻau ma mua, a me kou hiki ke ʻae i nā lapaʻau like ʻole i ke kūkākūkā ʻana i nā koho ʻē aʻe.

ʻO ka lāʻau lapaʻau CAR-T cell kekahi o nā koho ʻē aʻe e hoʻohiki nei no nā maʻi me ka lymphoma nui B-cell i hoʻi hou. Hoʻopili kēia lapaʻau i ka wehe ʻana i kāu mau pūnaewele immune ponoʻī, hoʻololi genetically iā lākou e hakakā maikaʻi i ka maʻi kanesa, a laila hoʻokomo hou iā lākou i loko o kou kino. ʻOiai he mea maikaʻi loa, pono ka lāʻau lapaʻau CAR-T cell i nā kikowaena kūikawā a hiki ke hana i nā hopena ʻaoʻao kūikawā.

ʻO nā mea hoʻohui antibody-drug ʻē aʻe e like me polatuzumab vedotin he mau koho paha e pili ana i nā hōʻailona kikoʻī o kāu maʻi kanesa. Hiki nō hoʻi ke noʻonoʻo ʻia nā hui chemotherapy kuʻuna, nā hoʻokolohua lapaʻau me nā lapaʻau hoʻokolohua, a i ʻole ka transplantation stem cell ma muli o kou mau kūlana pilikino.

Eia kekahi mau lapaʻau ʻē aʻe e kūkākūkā ai kāu oncologist:

• Lāʻau lapaʻau CAR-T cell (tisagenlecleucel a i ʻole axicabtagene ciloleucel)
• Polatuzumab vedotin i hui pū ʻia me ka chemotherapy
• Nā hoʻokolohua lapaʻau me nā lāʻau noiʻi hou
• Autologous a i ʻole allogeneic stem cell transplantation
• Nā papa hana chemotherapy hui e like me R-ICE a i ʻole R-DHAP
• Lāʻau radiation no ka maʻi localized

Na kāu hui mālama ola e kōkua iā ʻoe e hoʻomaopopo i nā pōmaikaʻi a me nā hemahema o kēlā me kēia koho a alakaʻi iā ʻoe i ka lāʻau lapaʻau kūpono loa no kou kūlana kikoʻī.

Ua ʻoi aku ka maikaʻi o Loncastuximab Tesirine ma mua o Rituximab?

Hana ʻokoʻa ʻo Loncastuximab tesirine a me rituximab a hoʻohana ʻia ma nā pae like ʻole o ka mālama ʻana i ka lymphoma, e paʻakikī ana i nā hoʻohālikelike pololei. ʻO ka maʻamau, he ʻāpana ʻo Rituximab o nā hui lapaʻau laina mua, ʻoiai ua mālama ʻia ʻo loncastuximab tesirine no nā maʻi i hoʻi hou a ʻaʻole i pane i nā lāʻau lapaʻau mua he nui me rituximab.

He antibody monoclonal ʻo Rituximab e kuhikuhi ana iā CD20 ma nā B-cells a he pōhaku kihi o ka mālama ʻana i ka lymphoma no nā makahiki he nui. ʻO ka maʻamau, ua ʻae maikaʻi ʻia a hui pinepine ʻia me ka chemotherapy i nā regimens e like me R-CHOP. ʻO Loncastuximab tesirine, he antibody-drug conjugate e kuhikuhi ana iā CD19, hāʻawi pololei i ka chemotherapy i nā sela maʻi akā ʻoi aku ka nui o nā hopena ʻaoʻao.

I ka pōʻaiapili o ka maʻi i hoʻi hou a i ʻole refractory, hiki i ka loncastuximab tesirine ke hāʻawi i nā pōmaikaʻi ʻaʻole hiki i nā lāʻau lapaʻau i hoʻokumu ʻia e rituximab ke hāʻawi. Eia naʻe, e noʻonoʻo kāu oncologist i kāu mōʻaukala lapaʻau piha, ke kūlana olakino o kēia manawa, a me nā ʻano maʻi e hoʻoholo ai i ke ala kūpono loa no kou kūlana kikoʻī.

Nā nīnau i nīnau pinepine ʻia e pili ana iā Loncastuximab Tesirine

Q1. He palekana ʻo Loncastuximab Tesirine no nā maʻi me ka maʻi ate?

Hiki i ka Loncastuximab tesirine ke hoʻopilikia i ka hana ate, no laila pono nā maʻi me ka maʻi ate e loiloi pono ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau. E nānā kāu oncologist i kāu mau hoʻokolohua hana ate a me ke olakino ate holoʻokoʻa e hoʻoholo ai inā palekana kēia lāʻau lapaʻau iā ʻoe. Inā he maʻi ate maʻalahi kāu, hiki i kāu kauka ke ʻōlelo aku i ka lāʻau lapaʻau me ka nānā ʻana i ka nānā ʻana, akā ʻo ka maʻi ate koʻikoʻi e hana maʻamau i kēia lāʻau lapaʻau.

I ka wā o ka mālama ʻana, e nānā mau kāu hui mālama ola i ka hana o kou ate ma o nā hoʻokolohua koko. Inā kū mai a ʻoi aku paha nā pilikia o ke ake i ka wā o ka mālama ʻana, pono paha ke kauka e hoʻoponopono i kāu mahele, hoʻopaneʻe i ka mālama ʻana, a i ʻole e hoʻololi i kahi lāʻau lapaʻau ʻē aʻe. He mea nui e hōʻike i nā hōʻailona e like me ka melemele o ka ʻili a i ʻole nā maka, ka mimi ʻeleʻele, a i ʻole ka luhi nui i kāu hui lapaʻau.

Q2. He aha kaʻu e hana ai inā loaʻa iaʻu ka nui loa o Loncastuximab Tesirine?

No ka mea, hāʻawi ʻia ʻo loncastuximab tesirine i nā wahi mālama ola e nā poʻe loea i hoʻomaʻamaʻa ʻia, he mea maʻamau loa ka overdose ulia pōpilikia. Hoʻomākaukau pono ʻia ka lāʻau a hāʻawi ʻia e like me nā protocols koʻikoʻi, me nā loiloi palekana he nui. Eia naʻe, inā hopohopo ʻoe e pili ana i ka loaʻa ʻana o kahi mahele hewa, mai kānalua e kamaʻilio me kāu hui mālama ola.

Inā loaʻa kahi overdose, e hāʻawi kāu hui lapaʻau i ka mālama kākoʻo e mālama i nā hōʻailona e kū mai. Hiki i kēia ke komo i nā lāʻau lapaʻau e pale ai i ka nausea, nā lāʻau lapaʻau e kākoʻo i kāu helu koko, a i ʻole nā hana ʻē aʻe e pili ana i kāu mau pono kikoʻī. Loaʻa i ka hale mālama ola nā protocols e mālama ai i ia mau kūlana a e nānā pono iā ʻoe.

Q3. He aha kaʻu e hana ai inā hala iaʻu kahi mahele o Loncastuximab Tesirine?

Inā hala ʻoe i kahi manawa hoʻokomo i hoʻonohonoho ʻia, e hoʻokaʻaʻike i kāu hui mālama ola i ka hiki wawe e hoʻonohonoho hou. Mai kali no kāu manawa i hoʻonohonoho ʻia e hiki mai ana, no ka mea, he mea nui ka mālama ʻana i kāu papa hana lapaʻau no ka pono o ka lāʻau. E hoʻoholo kāu oncologist i ka manawa maikaʻi loa no kāu mahele e hiki mai ana e pili ana i ka lōʻihi o ka hala ʻana mai kāu lapaʻau hope loa.

ʻAʻole e hōʻino ka hala ʻana i kahi lāʻau i kāu lapaʻau, akā he mea nui e hoʻi koke i ke ala. Hiki i kāu hui mālama ola ke hoʻoponopono i kāu papa hana a i ʻole e hāʻawi i ka nānā hou e hōʻoia e loaʻa ana iā ʻoe ka mālama maikaʻi loa. Hoʻomaopopo lākou i kekahi manawa e keakea nā kūlana ola i nā papa hana lapaʻau a e hana pū me ʻoe e mālama i kāu lapaʻau.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Loncastuximab Tesirine?

Pono e hana mau ʻia ka hoʻoholo e hooki i ka loncastuximab tesirine ma ke kūkākūkā ʻana me kāu oncologist, ʻaʻole ma kāu iho. Hoʻomau maʻamau ka lapaʻau a hiki i ka wā e pau ai ka pane ʻana o kāu maʻi maʻi i ka lāʻau, ʻike ʻoe i nā hopena ʻaoʻao ʻae ʻole, a i ʻole e hoʻopau ʻoe i ka papa hana i hoʻolālā ʻia. E hoʻohana kāu kauka i nā scans maʻamau a me nā hoʻokolohua koko e nānā i kāu holomua a e hoʻoholo i ka lōʻihi o ka lapaʻau.

Hiki i kekahi poʻe maʻi ke hoʻopau i kā lākou mau pōʻai lapaʻau i hoʻolālā ʻia a laila komo i kahi pae nānā, aʻo nā mea ʻē aʻe e pono e hooki koke ma muli o nā hopena ʻaoʻao a i ʻole ka nele o ka pane. E kūkākūkā kāu oncologist i nā hōʻailona e hōʻike ana i ka wā e pono ai e pau ka lapaʻau a kōkua iā ʻoe e hoʻomaopopo i ka mea e manaʻo ai i ka wā o ka hoʻololi ʻana i ka mālama ma hope.

Q5. Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana iā Loncastuximab Tesirine?

Pono ka hoʻomaopopo pono ʻana a me ke alakaʻi ʻana mai kāu hui mālama ola i ka wā e lapaʻau ai i ka loncastuximab tesirine. Pono e pale ʻia nā lāʻau lapaʻau ola i ka wā o ka lapaʻau a no kekahi mau mahina ma hope mai no ka mea e hoʻopaʻa ʻia kāu ʻōnaehana pale. Eia naʻe, hiki ke ʻōlelo ʻia nā lāʻau lapaʻau ʻole e like me ka pana flu a i ʻole nā lāʻau lapaʻau COVID-19, ʻoiai ʻaʻole paha lākou i ʻoi aku ka maikaʻi ma mua o ka maʻamau.

E hana pū ana kāu kauka oncologist me ʻoe e hoʻoholo i nā lāʻau lapaʻau kūpono a me ka manawa e loaʻa ai lākou. Manaʻo ʻia e hoʻomaikaʻi i nā lāʻau lapaʻau ma mua o ka hoʻomaka ʻana i ka mālama ʻana inā hiki. E hōʻike mau i kekahi mea mālama ola e pili ana i kāu mālama ʻana i ka maʻi kanesa ma mua o ka loaʻa ʻana o nā lāʻau lapaʻau e hōʻoia i ka palekana a me ke kūpono no kou kūlana.